sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
GRCE
Updated 10/6/2026, 10:27 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| GRCE Grace Therapeutics, Inc. | Buy | $123,819 | Opaleye Management Inc. 10% owner | 60,490 sh | at $2.05 | Filed Oct 5, 6:46 PM ET | Filing | |
| GRCE Grace Therapeutics, Inc. | Buy | $16,404 | Opaleye Management Inc. 10% owner | 7,849 sh | at $2.09 | Filed Oct 1, 4:30 PM ET | Filing | |
| GRCE Grace Therapeutics, Inc. | Buy | $31,687 | Opaleye Management Inc. 10% owner | 15,089 sh | at $2.10 | Filed Oct 1, 4:05 PM ET | Amended | Filing |
| GRCE Grace Therapeutics, Inc. | Buy | $31,687 | Opaleye Management Inc. 10% owner | 15,089 sh | at $2.10 | Filed Sep 23, 6:19 PM ET | Filing | |
| GRCE Grace Therapeutics, Inc. | Buy | $31,896 | Opaleye Management Inc. 10% owner | 15,229 sh | at $2.09 | Filed Sep 10, 4:05 PM ET | Filing | |
| GRCE Grace Therapeutics, Inc. | Buy | $214,000 | Kohli Prashant Chief Executive Officer, Director | 100,000 sh | at $2.14 | Filed Sep 10, 7:30 AM ET | Filing | |
| GRCE Grace Therapeutics, Inc. | Buy | $24,206 | Opaleye Management Inc. 10% owner | 11,608 sh | at $2.09 | Filed Aug 19, 7:44 AM ET | Filing |